drugset / Trial / NCT01021540
Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine if H.P. Acthar Gel (repository corticotrophin) has the same anti-proteinuric effects seen with the synthetic ACTH analogue in Europe.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Repository corticotrophin | Unknown | 80 iu | Subcutaneous |